Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Mayne Pharma Group Ltd (PK) MAYNF

Healthcare Drug Manufacturers - Major
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract... see more

Current News (PINL:MAYNF)

Mayne Pharma launches another generic oral contraceptive

PR Newswire March 4, 2021

New Data On Mayne Pharma's Tolsura® (SUBA®-itraconazole) Presented At IDWeek 2020

PR Newswire October 26, 2020

Mayne Pharma Launches Chlorzoxazone Tablet in the United States

PR Newswire July 27, 2020

Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US

PR Newswire June 24, 2020

Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia

PR Newswire May 28, 2020

Mayne Pharma launches BAC 300 capsules in the United States

PR Newswire May 22, 2020

Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA

PR Newswire April 16, 2020

Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US

PR Newswire October 2, 2019

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis

PR Newswire May 22, 2019
View More News ››

Opinion & Analysis (PINL:MAYNF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:MAYNF)

First

This company is doing work. With its aqusition of Metrics Inc., the SUBA CAP in europe and 10 products which are currently under...
Josue1 - March 21, 2014
View more Bullboard ››

Nuclear Vision Ltd.

Nuclear Vision Ltd.

Nuclear Vision Limited operates as a uranium exploration company. Its material property is the Regnault Project that consists ...
View More »